Furthermore, Himbert et al. highlight the potential role of the baseline immunoglobulin E (IgE) isotype of anti-dsDNA antibodies for predicting LN flares during the 24 months of follow-up in the WIN-IgE study (Sn 40%, Sp 90%) [97]. This evidence concerns the gene IGHE and lobular neoplasia.